Literature DB >> 9051359

Adrenomedullin--physiological regulator of the cardiovascular system or biochemical curiosity?

K Kitamura1, T Eto.   

Abstract

Adrenomedullin is a potent vasodilator peptide that exerts major effects on cardiovascular function. Adrenomedullin is biosynthesized in a wide variety of organs and cells, although it was initially isolated from human pheochromocytoma tissue. In addition to adrenomedullin, proadrenomedullin N-terminal 20 peptide was found to be processed from adrenomedullin precursor. Both adrenomedullin and proadrenomedullin N-terminal 20 peptide show hypotensive effects in anesthetized rats, but exhibit different hypotensive mechanisms. Further, adrenomedullin possesses multiple biological effects involved in cardiovascular homeostasis. Plasma adrenomedullin concentration is increased in patients with cardiovascular diseases such as hypertension, congestive heart failure, renal failure and septic shock. The present review summarizes the recent advancement of adrenomedullin research and demonstrates that adrenomedullin is one of the important vasoactive peptides involved in the physiology and pathophysiology of circulatory control and control of body fluid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051359     DOI: 10.1097/00041552-199701000-00015

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  6 in total

1.  Possible involvement of adrenomedullin in lipopolysaccharide-induced small-intestinal motility changes in conscious rats.

Authors:  Sarwar Hussain; Reiko Miyazawa; Takeshi Tomomasa; Hiroaki Kaneko; Atsushi Takahashi; Toshio Watanabe; Hirokazu Arakawa; Akihiro Morikawa
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

2.  Pathophysiological functions of adrenomedullin and natriuretic peptides in patients with primary aldosteronism.

Authors:  Wei Hu; Pang-hu Zhou; Xiao-bin Zhang; Chang-geng Xu; Wei Wang
Journal:  Endocrine       Date:  2014-06-11       Impact factor: 3.633

Review 3.  [Role of adrenomedullin in the pathogenesis and treatment of cardiovascular dysfunctions and sepsis].

Authors:  M Westphal; J Sander; H Van Aken; C Ertmer; H D Stubbe; M Booke
Journal:  Anaesthesist       Date:  2006-02       Impact factor: 1.041

Review 4.  Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.

Authors:  Jeremy Cypen; Tariq Ahmad; Jeffrey M Testani; Adam D DeVore
Journal:  Curr Heart Fail Rep       Date:  2017-10

5.  Adrenomedullin inhibits spontaneous and bradykinin-induced but not oxytocin- or prostaglandin F(2alpha)-induced periodic contraction of rat uterus.

Authors:  T Yanagita; R Yamamoto; T Sugano; H Kobayashi; Y Uezono; H Yokoo; S Shiraishi; S I Minami; A Wada
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Plasma concentrations of adrenomedullin and natriuretic peptides in patients with essential hypertension.

Authors:  Wei Hu; Pang-Hu Zhou; Xiao-Bin Zhang; Chang-Geng Xu; Wei Wang
Journal:  Exp Ther Med       Date:  2015-03-11       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.